Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.

作者: Mickaël Jean , Jacques Renault , Nicolas Levoin , Denis Danvy , Thierry Calmels

DOI: 10.1016/J.BMCL.2010.07.096

关键词:

摘要: Isosteric replacement of the amide function and modulation arylpiperazine moiety known dopamine D3 receptor ligands led to potent selective compounds. Enhanced bioavailability preferential brain distribution make compound 6c a good candidate for pharmacological clinical evaluation.

参考文章(19)
Pierre Sokoloff, Bruno Giros, Marie-Pascale Martres, Marie-Louise Bouthenet, Jean-Charles Schwartz, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. ,vol. 347, pp. 146- 151 ,(1990) , 10.1038/347146A0
Marcello Leopoldo, Francesco Berardi, Nicola A. Colabufo, Paola De Giorgio, Enza Lacivita, Roberto Perrone, Vincenzo Tortorella, Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D3 receptor ligands Journal of Medicinal Chemistry. ,vol. 45, pp. 5727- 5735 ,(2002) , 10.1021/JM020952A
Laura Bettinetti, Karin Schlotter, Harald Hübner, Peter Gmeiner, Interactive SAR Studies: Rational Discovery of Super-Potent and Highly Selective Dopamine D3 Receptor Antagonists and Partial Agonists Journal of Medicinal Chemistry. ,vol. 45, pp. 4594- 4597 ,(2002) , 10.1021/JM025558R
Jun Yuan, Xi Chen, Robbin Brodbeck, Renee Primus, Julia Braun, Jan W.F. Wasley, Andrew Thurkauf, NGB 2904 and NGB 2849: Two highly selective dopamine D3 receptor antagonists Bioorganic & Medicinal Chemistry Letters. ,vol. 8, pp. 2715- 2718 ,(1998) , 10.1016/S0960-894X(98)00469-7
Wenhua Chu, Zhude Tu, Elizabeth McElveen, Jinbin Xu, Michelle Taylor, Robert R. Luedtke, Robert H. Mach, Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry. ,vol. 13, pp. 77- 87 ,(2005) , 10.1016/J.BMC.2004.09.054
Daniela Huber, Harald Hübner, Peter Gmeiner, 1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands. Journal of Medicinal Chemistry. ,vol. 52, pp. 6860- 6870 ,(2009) , 10.1021/JM901120H
Philipp Heidler, Vida Zohrabi-Kalantari, Thierry Calmels, Marc Capet, Isabelle Berrebi-Bertrand, Jean-Charles Schwartz, Holger Stark, Andreas Link, Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides. Bioorganic & Medicinal Chemistry. ,vol. 13, pp. 2009- 2014 ,(2005) , 10.1016/J.BMC.2005.01.018
P. John Murray, Lee A. Harrison, Martin R. Johnson, Graeme M. Robertson, David I.C. Scopes, David R. Bull, Elizabeth A. Graham, Ann G. Hayes, Gavin J. Kilpatrick, Izaak Den Daas, Charles Large, Michael J. Sheehan, Carole M. Stubbs, Michael P. Turpin, A novel series of arylpiperazines with high affinity and selectivity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters. ,vol. 5, pp. 219- 222 ,(1995) , 10.1016/0960-894X(95)00011-H
Maria Pilla, Sylvie Perachon, FranÇois Sautel, Fabrice Garrido, André Mann, Camille G. Wermuth, Jean-Charles Schwartz, Barry J. Everitt, Pierre Sokoloff, Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. ,vol. 400, pp. 371- 375 ,(1999) , 10.1038/22560
Anneke Hackling, Robin Ghosh, Sylvie Perachon, André Mann, Hans-Dieter Höltje, Camille G. Wermuth, Jean-Charles Schwartz, Wolfgang Sippl, Pierre Sokoloff, Holger Stark, N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands Journal of Medicinal Chemistry. ,vol. 46, pp. 3883- 3899 ,(2003) , 10.1021/JM030836N